|Articles|April 14, 2003
Preliminary trials with Light-Adjustable Lens are promising
San Francisco-April 13-The Light-Adjustable Lens (LAL) has entered humanclinical trials with promising results. Four humans-one blind and threewith sight-have received the lens, noted Robert K. Maloney, MD, chief medicalofficer, Calhoun Vision Inc, Pasadena, CA, who spoke at dinner gatheringin San Francisco.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
EURETINA 2026: 3 gene therapy programmes for nAMD approaching phase 3 readouts
2
EURETINA 2026: Real-world evidence on retinal biosimilars
3
EURETINA 2026: Eyestem interim Phase 2 results for clinical study of Eyecyte-RPE for GA secondary to dry AMD
4
FAQ: What clinicians need to know about OCU410 phase 2 ArMaDa results
5















